Vyant Bio Inc Watch

EX-1.1

from 8-K 38 pages Vyant Bio, Inc. Equity Distribution Agreement

12/34/56

EX-1.1

from 8-K 41 pages At the Market Offering Agreement

12/34/56

EX-1.1

from 425 35 pages 1,363,637 Shares of Common Stock Cancer Genetics, Inc. Amended and Restated Underwriting Agreement

12/34/56

EX-1.1

from 8-K 35 pages 1,363,637 Shares of Common Stock Cancer Genetics, Inc. Amended and Restated Underwriting Agreement

12/34/56

EX-1.1

from 8-K 41 pages 13,333,334 Shares of Common Stock Cancer Genetics, Inc. Underwriting Agreement

12/34/56

EX-1.1

from 8-K 42 pages Cancer Genetics, Inc. Underwriting Agreement

12/34/56

EX-1.1

from 8-K 44 pages Cancer Genetics, Inc. Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement

12/34/56

EX-1

from SC 13G/A 2 pages Exhibit 1 Joint Filing Agreement

12/34/56

EX-1.1

from S-1/A 34 pages Underwriting Agreement Between Cancer Genetics, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Cancer Genetics, Inc. Underwriting Agreement

12/34/56

EX-1.1

from 8-K 35 pages Underwriting Agreement Between Cancer Genetics, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Cancer Genetics, Inc. Underwriting Agreement

12/34/56

EX-1.1

from S-1/A 35 pages Underwriting Agreement Between Cancer Genetics, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Cancer Genetics, Inc. Underwriting Agreement

12/34/56

EX-1.1

from S-1/A 36 pages Underwriting Agreement Between Cancer Genetics, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Cancer Genetics, Inc. Underwriting Agreement

12/34/56

EX-1.1

from S-1/A 37 pages Underwriting Agreement Between Cancer Genetics, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters

12/34/56

EX-1.1

from S-1/A 40 pages Cancer Genetics, Inc. Shares of Common Stock Underwriting Agreement

12/34/56